Journal of Urology

The Journal of Urology is a peer-reviewed scientific journal of urology published by Elsevier on behalf of the American Urological Association. It was established in 1917. The journal is abstracted and indexed in BIOSIS, Current Contents/Clinical Medicine, EMBASE/Excerpta Medica, MEDLINE, Reference Update, and Scopus.

Publisher
Elsevier
History
1917–present

Some content from Wikipedia, licensed under CC BY-SA

Obstetrics & gynaecology

Tension-free vaginal tape-obturator has lasting benefit

(HealthDay)—The tension-free vaginal tape-obturator procedure is usually still effective at 10 years after the procedure, according to a study published in the October issue of The Journal of Urology.

Surgery

Rate of genitourinary injuries up among U.S. service men

(HealthDay)—A total of 1,367 male U.S. service members deployed to Operation Iraqi Freedom/Operation Enduring Freedom sustained genitourinary injury, according to a study published in the February issue of The Journal of ...

Diseases, Conditions, Syndromes

Identifying overactive bladder issues just got easier

Biomedical researchers at Massey University have just published ground-breaking research that could lead to faster diagnosis of bladder problems in women, in a leading specialist journal, the British Journal of Urology.

Diseases, Conditions, Syndromes

Collagenase clostridium histolyticum OK in Peyronie's

(HealthDay)—For patients with Peyronie's disease, treatment with collagenase clostridium histolyticum (CCH) intralesional injections is efficacious and tolerable, according to research published online Feb. 1 in The Journal ...

Oncology & Cancer

Comorbidity tied to prostate cancer upgrading, up staging

(HealthDay)—Comorbidity burden is strongly and independently associated with pathological upgrading/up staging in men with clinically low-risk prostate cancer, according to a study published in the April issue of The Journal ...

Diabetes

Diabetes predicts worse survival in renal cell carcinoma

(HealthDay)—Diabetes mellitus is associated with worse prognosis in terms of progression-free, overall, and cancer-specific survival in patients with renal cell carcinoma treated surgically, according to a study published ...

Diseases, Conditions, Syndromes

PSA cut point of more than 0.4 ng/mL predicts progression

(HealthDay)—A prostate-specific antigen cut point of ≥0.4 ng/mL predicts future disease progression, according to a study published in the June issue of The Journal of Urology.

Oncology & Cancer

Impact of 2012 USPSTF guideline against PSA screening explored

(HealthDay)—Patients undergoing prostate needle biopsies after the 2012 U.S. Preventive Services Task Force (USPSTF) recommendation against prostate-specific antigen-based screening for prostate cancer for men of any age ...

page 1 from 24